Add to MyYahoo RSS

Pharmaceutical News

Pharmaceuticals news continually updated from thousands of sources around the net.

37 min ago |

Achillion Pharmaceuticals Given "Neutral" Rating by Edison Group Analysts

The analysts wrote, "Achillion holds the promise of developing an all-oral HCV regimen that can be competitive in the evolving HCV treatment landscape.


Related Topix: Achillion Pharmaceuticals

Thu Apr 24, 2014


HIV May Be Manageable But It Ain't Cheap

Phil Lauderhill takes medications daily to treat his condition. Lauderhill, 36, has been HIV positive for 10 years now, but like most people cannot afford to pay for his treatment alone.


Related Topix: HIV/AIDS, Health, Health Insurance

Global pharmaceuticals market: Latest market analysis presented

The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in June 2013.


Related Topix: Pharmacology

Pharmatek Doubles Api-in-Capsule Manufacturing Capacity Leading to Cost Savings for Clients

LIGHTNING RELEASES: SAN DIEGO, Calif. - Pharmatek, a contract development and manufacturing organization supporting the pharmaceutical industry, today announced the launch of the Company's new API-in-capsule manufacturing program.


BioResearch Online

Patient Demand, Vaccines, And Drug Delivery: Q&A With Steve Wick Of 3M Drug Delivery Systems

New technologies are changing the drug delivery approaches used for both small and large molecule manufacturers.


Related Topix: Manufacturing, 3M, Chemicals

The Motley Fool

Earnings Roundup: What You Need to Know About Gilead's Blockbuster Quarter

Sovaldi's sales totaled $2.3 billion in the first quarter as patients previously warehoused by doctors clamored for the new cure.


Related Topix: Hepatitis, Medicine, Health, HIV/AIDS, Pharmasset

JD Supra

Legal and Ethical Risks of Healthcare Businesses in China

Recent disputes and controversies involving Chinese subsidiaries of foreign pharmaceutical companies have sounded warning bells on legal and ethical issues regarding participation in China's rapidly growing and evolving pharmaceutical market.


Related Topix: Healthcare, Prison

Wed Apr 23, 2014

Hispanic Business

Bioserv Corp. Appoints Schrier as SVP of Pharmaceutical Technologies

According to a release, Dr. Schrier brings over 25 years of broad analytical and pharmaceutical development experience to Bioserv and has helped create numerous cGMP-compliant analytical and pharmaceutical development departments within the pharmaceutical industry.


Related Topix: Medicine, Kogenate, Antihemophilic Factor (generic)


VIDEO: GSK and Novartis deal 'shows focus'

Earlier this week, two giants of the pharmaceutical industry Novartis and GlaxoSmithKline struck a multi-billion-dollar deal to join forces and reshape their businesses.


Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry

Sys-Con Media

Frutarom Launches New Phytopharmaceutical Ingredients Line

The new product line for the pharmaceutical industry expands the established EFLAA brand, offering increased value to the pharmaceutical industry plus expertise in building a supply chain for sustainable, natural Active Pharmaceutical Ingredients that meet pharmaceutical manufacturers' needs.


The Motley Fool

Allergan, Inc.: Another Billion-Dollar Buyout Target

Earlier this week, investors following the pharmaceutical industry may have been surprised to hear that Pfizer was interested in acquiring AstraZeneca .


Related Topix: Allergan, Biotech, Financial Markets

Sentinel & Enterprise

Federal grant to help finish Devens road reconstruction

The final stretch of the Jackson Road reconstruction project will receive a helping hand from the federal government, as the U.S. Economic Development Administration announced a $1.85 million grant to the Massachusetts Development Finance Agency on Tuesday.


Related Topix: Devens, MA, Bristol Myers Squibb, US Military, US Army, Fort Devens, Fort Devens, MA


Bayer asks Japan to approve Riociguat drug

Bayer AG has requested regulatory approval for its riociguat drug which is for the treatment of pulmonary arterial hypertension, the German pharmaceutical company said Wednesday.


Related Topix: Manufacturing, Biotech, Bayer AG, Chemicals, e-Spirit

Tue Apr 22, 2014

The Independent

James Moore: Frenetic activity won't fix the pharmaceutical industry's problems

Outlook The pharmaceutical sector is creating more excitement in the world's financial centres than the opening of a warehouse full of free Viagra in a retirement community.



Bristol-Myers Squibb and Samsung BioLogics Expand Manufacturing Agreement

NEW YORK & SEOUL, South Korea -- -- Bristol-Myers Squibb Company and Samsung BioLogics today announced the companies will increase the scope of their existing manufacturing agreement in which Samsung will manufacture commercial drug substances and drug product for several Bristol-Myers Squibb biologic medicines at its Incheon manufacturing site.


Related Topix: Bristol Myers Squibb, Biotech, Medicine, Healthcare Industry, Bristol-Myers Squibb, Bloomsbury Publishing, Media, Publishing, Medarex, South Korea, World News


BMS Files for FDA Approval of Reyataz/Cobicistat Combo Pill

Bristol-Myers Squibb has filed a new drug application with the U.S. Food and Drug Administration for a fixed-dose combination tablet of Reyataz and cobicistat for the treatment of HIV.


Related Topix: Reyataz, Atazanavir Sulfate (generic), Healthcare Law, Food and Drug Administration, Law, Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medicine, Healthcare Industry


Stocks up after good earnings, pharma deal

The Dow , S&P 500 , and Nasdaq all rose in morning trading as investors welcomed news from several big companies and news of mergers in the pharmaceutical industry.


Related Topix: Financial Markets

Africa Pharmaceutical Summit Coming To Accra

This year, AFRICA PHARMACEUTICAL SUMMIT comes to Accra's MA venpick Ambassador Hotel, taking place from 10 to 11 September.


The Advertiser

Glaxo agrees 9.5bn drugs deal

GLAXOSMITHKLINE and Swiss rival Novartis are to create a consumer healthcare powerhouse as part of a string of deals in the pharmaceuticals sector today.


Related Topix: GLAXOSMITHKLINE, Biotech, GlaxoSmithKline

Mon Apr 21, 2014

Business Journal

Impax Laboratories picks Frederick Wilkinson as CEO

Wilkinson, a research and development executive at Actavis plc, starts work April 29. He takes over from Larry Hsu , who is retiring as CEO of Hayward-based Impax .


Related Topix: Biotech, Impax Laboratories, Medicine, Healthcare Industry, Startups


Pharmaceuticals Jobs